BCI-Controlled Devices for Motor Disorders
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores new methods to help people with motor disorders regain better movement control. It uses brain-computer interfaces (BCIs) to interpret brain signals and control assistive devices, potentially enhancing rehabilitation. The study focuses on two main approaches: using electrical stimulation to boost brain signal stability and distinguishing specific hand movements. It may suit individuals with motor issues from conditions like stroke or spinal cord injuries, who have normal or corrected vision and can read and understand English. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could improve rehabilitation methods for motor disorders.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it excludes participants on heavy medication affecting the central nervous system. It's best to discuss your specific medications with the trial team.
What prior data suggests that these BCI-controlled devices are safe for motor disorder rehabilitation?
Research has shown that transcutaneous electrical spinal stimulation (TESS) can make spinal nerves more responsive, potentially activating certain nerve pathways. Studies have also explored its role in helping people with spinal cord injuries regain movement. No major negative effects have been reported, suggesting it is generally safe.
For neuromuscular electrical stimulation (NMES), research indicates it can significantly improve movement in stroke patients. It works by sending electrical signals to muscles, aiding in the understanding of motor imagery. Again, studies have not reported serious side effects, suggesting that NMES is generally safe for participants.
Both techniques are under study to assist with brain-computer interface (BCI) training, which enables the brain to control external devices. Past studies suggest that both TESS and NMES show promise for improving movement recovery with minimal risk to participants.12345Why are researchers excited about this trial?
Researchers are excited about these brain-computer interface (BCI)-controlled devices for motor disorders because they offer a non-invasive approach to assistive technology. Unlike traditional treatments that might involve medication or surgery, these devices use the power of the mind to control movements through motor imagery. The treatments incorporate innovative feedback methods, such as Transcutaneous Electrical Spinal Stimulation (TESS) and Neuromuscular Electrical Stimulation (NMES), which are thought to enhance the effectiveness of BCI training. This could potentially lead to more effective rehabilitation and improved motor function for individuals with motor disorders, offering a new hope for enhanced quality of life.
What evidence suggests that this trial's BCI-controlled devices could be effective for motor disorders?
This trial will compare different BCI-controlled assistive device training methods. One arm will use transcutaneous electrical spinal stimulation (TESS) before BCI training sessions. Research has shown that TESS can improve movement control by facilitating brain signal transmission to muscles, potentially accelerating the learning of BCI tasks. Specifically, studies have found that just a few TESS sessions can enhance movement and sensation, with effects lasting at least a week.
Another arm will focus on the NMES approach, combining neuromuscular electrical stimulation (NMES) with BCI training. Many studies suggest that this combination can significantly enhance movement abilities. NMES helps distinguish between different imagined movements, improving the use of assistive devices. This combined method has been particularly effective in enhancing movement in stroke patients.26789Who Is on the Research Team?
Jose del R. Millan, PhD
Principal Investigator
The University of Texas at Austin
Are You a Good Fit for This Trial?
This trial is for people with certain motor disabilities (like stroke, spinal cord injury, or muscular diseases) and healthy individuals with normal vision. Participants must understand English and be able to consent. Those with serious illnesses, attention/cognitive issues preventing focus during sessions, heavy central nervous system medication, or conditions affecting EEG/EMG data collection can't join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Training
Participants undergo BCI training with transcutaneous electrical spinal stimulation and neuromuscular electrical stimulation to improve motor imagery control.
Follow-up
Participants are monitored for changes in BCI command delivery performance and SMR modulation strength.
Long-term Follow-up
Participants are assessed for stability and separability of motor imagery features and changes in fMRI activations.
What Are the Treatments Tested in This Trial?
Interventions
- Non-invasive BCI-controlled Assistive Devices
Non-invasive BCI-controlled Assistive Devices is already approved in United States, European Union for the following indications:
- Rehabilitation for stroke survivors with chronic motor deficits
- Assistive technology for individuals with severe motor impairments
- Assistive technology for individuals with spinal cord injuries
- Rehabilitation for individuals with motor impairments
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas at Austin
Lead Sponsor